In addition, inhibition of AC5 also protects against physical frailty, enhances exercise capacity, and protects against diabetes, obesity and diabetic cardiomyopathy [14, 20, 52]. Here, ADCY5 is linked to obesity due to melanocortin 4 receptor deficiency.